Restricted accessResearch articleFirst published online 2014-06
Age-Related Decreases of Serum-Response Factor Levels in Human Mesenchymal Stem Cells Are Involved in Skeletal Muscle Differentiation and Engraftment Capacity
Skeletal muscle (SkM) comprise ∼40% of human body weight. Injury or damage to this important tissue can result in physical disability, and in severe cases is difficult for its endogenous stem cell—the satellite cell—to reverse effectively. Mesenchymal stem cells (MSC) are postnatal progenitor/stem cells that possess multilineage mesodermal differentiation capacity, including toward SkM. Adult bone marrow (BM) is the best-studied source of MSCs; however, aging also decreases BMMSC numbers and can adversely affect differentiation capacity. Therefore, we asked whether human sources of developmentally early stage mesenchymal stem cells (hDE-MSCs) isolated from embryonic stem cells, fetal bone, and term placenta could be cellular sources for SkM repair. Under standard muscle-inducing conditions, hDE-MPCs differentiate toward a SkM lineage rather than cardiomyocytic or smooth muscle lineages, as evidenced by increased expression of SkM-associated markers and in vitro myotube formation. In vivo transplantation revealed that SkM-differentiated hDE-MSCs can efficiently incorporate into host SkM tissue in a mouse model of SkM injury. In contrast, adult BMMSCs do not express SkM-associated genes after in vitro SkM differentiation nor engraft in vivo. Further investigation of possible factors responsible for this difference in SkM differentiation potential revealed that, compared with adult BMMSCs, hDE-MSCs expressed higher levels of serum response factor (SRF), a transcription factor critical for SkM lineage commitment. Moreover, knockdown of SRF in hDE-MSCs resulted in decreased expression of SkM-related genes after in vitro differentiation and decreased in vivo engraftment. Our results implicate SRF as a key factor in age-related SkM differentiation capacity of MSCs, and demonstrate that hDE-MSCs are possible candidates for SkM repair.
Get full access to this article
View all access options for this article.
References
1.
JarvinenTA, JarvinenTL, KaanainenM, KalimoH and JarvinenM. (2005). Muscle injuries: biology and treatment. Am J Sports Med, 33:745–764.
2.
PaylorB, NatarajanA, ZhangRH and RossiF. (2011). Nonmyogenic cells in skeletal muscle regeneration. Curr Top Dev Biol, 96:139–165.
3.
PittengerMF, MackayAM, BeckSC, JaiswalRK, DouglasR, MoscaJD, MoormanMA, SimonettiDW, CraigS and MarshakDR. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284:143–147.
da Silva MeirellesL, ChagastellesPC and NardiNB. (2006). Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci, 119:2204–2213.
6.
BrookeG, CookM, BlairC, HanR, HeazlewoodC, JonesB, KambourisM, KollarK, McTaggartS, et al. (2007). Therapeutic applications of mesenchymal stromal cells. Semin Cell Dev Biol, 18:846–858.
7.
RaoMS and MattsonMP. (2001). Stem cells and aging: expanding the possibilities. Mech Ageing Dev, 122:713–734.
8.
RomanovYA, SvintsitskayaVA and SmirnovVN. (2003). Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells, 21:105–110.
9.
FukuchiY, NakajimaH, SugiyamaD, HiroseI, KitamuraT and TsujiK. (2004). Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells, 22:649–658.
10.
In‘t AnkerPS, ScherjonSA, Kleijburg-van der KeurC, de Groot-SwingsGM, ClaasFH, FibbeWE and KanhaiHH. (2004). Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells, 22:1338–1345.
11.
YenBL, HuangHI, ChienCC, JuiHY, KoBS, YaoM, ShunCT, YenML, LeeMC and ChenYC. (2005). Isolation of multipotent cells from human term placenta. Stem Cells, 23:3–9.
12.
GuillotPV, GotherstromC, ChanJ, KurataH and FiskNM. (2007). Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells, 25:646–654.
13.
HoPJ, YenML, TangBC, ChenCT and YenBL. (2013). H2O2 accumulation mediates differentiation capacity alteration, but not proliferative decline, in senescent human fetal mesenchymal stem cells. Antioxid Redox Signal, 18:1895–1905.
14.
TsaiMS, LeeJL, ChangYJ and HwangSM. (2004). Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod, 19:1450–1456.
15.
D'IppolitoG, SchillerPC, RicordiC, RoosBA and HowardGA. (1999). Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res, 14:1115–1122.
16.
StenderupK, JustesenJ, ClausenC and KassemM. (2003). Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone, 33:919–926.
17.
ZhouS, GreenbergerJS, EpperlyMW, GoffJP, AdlerC, LeboffMS and GlowackiJ. (2008). Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell, 7:335–343.
18.
LiS, CzubrytMP, McAnallyJ, Bassel-DubyR, RichardsonJA, WiebelFF, NordheimA and OlsonEN. (2005). Requirement for serum response factor for skeletal muscle growth and maturation revealed by tissue-specific gene deletion in mice. Proc Natl Acad Sci U S A, 102:1082–1087.
19.
GuerciA, LahouteC, HebrardS, CollardL, GraindorgeD, FavierM, CagnardN, Batonnet-PichonS, PrecigoutG, et al. (2012). Srf-dependent paracrine signals produced by myofibers control satellite cell-mediated skeletal muscle hypertrophy. Cell Metab, 15:25–37.
20.
YenBL, ChangCJ, LiuKJ, ChenYC, HuHI, BaiCH and YenML. (2009). Brief report—human embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytes. Stem Cells, 27:451–456.
21.
YenML, HouCH, PengKY, TsengPC, JiangSS, ShunCT, ChenYC and KuoML. (2011). Efficient derivation and concise gene expression profiling of human embryonic stem cell-derived mesenchymal progenitors (EMPs). Cell Transplant, 20:1529–1545.
22.
YenML, ChienCC, ChiuIM, HuangHI, ChenYC, HuHI and YenBL. (2007). Multilineage differentiation and characterization of the human fetal osteoblastic 1.19 cell line: a possible in vitro model of human mesenchymal progenitors. Stem Cells, 25:125–131.
23.
LawsonMA and PurslowPP. (2000). Differentiation of myoblasts in serum-free media: effects of modified media are cell line-specific. Cells Tissues Organs, 167:130–137.
24.
BurlacuA, RoscaAM, ManiuH, TitorencuI, DraganE, JingaV and SimionescuM. (2008). Promoting effect of 5-azacytidine on the myogenic differentiation of bone marrow stromal cells. Eur J Cell Biol, 87:173–184.
25.
MizunoH, ZukPA, ZhuM, LorenzHP, BenhaimP and HedrickMH. (2002). Myogenic differentiation by human processed lipoaspirate cells. Plast Reconstr Surg, 109:199–209; discussion 210–191.
26.
SchneiderCA, RasbandWS and EliceiriKW. (2012). NIH Image to ImageJ: 25 years of image analysis. Nat Methods, 9:671–675.
27.
WuCC, ChaoYC, ChenCN, ChienS, ChenYC, ChienCC, ChiuJJ and Linju YenB. (2008). Synergism of biochemical and mechanical stimuli in the differentiation of human placenta-derived multipotent cells into endothelial cells. J Biomech, 41:813–821.
28.
HillM and GoldspinkG. (2003). Expression and splicing of the insulin-like growth factor gene in rodent muscle is associated with muscle satellite (stem) cell activation following local tissue damage. J Physiol, 549:409–418.
29.
LianQ, LyeE, Yeo SuanK, Khia Way TanE, Salto-TellezM, LiuTM, PalanisamyN, El OakleyRM, LeeEH, LimB and LimSK. (2007). Derivation of clinically compliant MSCs from CD105+, CD24− differentiated human ESCs. Stem Cells, 25:425–436.
30.
LiuKJ, WangCJ, ChangCJ, HuHI, HsuPJ, WuYC, BaiCH, SytwuHK and YenBL. (2011). Surface expression of HLA-G is involved in mediating immunomodulatory effects of placenta-derived multipotent cells (PDMCs) towards natural killer lymphocytes. Cell Transplant, 20:1721–1730.
31.
WakitaniS, SaitoT and CaplanAI. (1995). Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve, 18:1417–1426.
32.
SeccoM, ZucconiE, VieiraNM, FogacaLL, CerqueiraA, CarvalhoMD, JazedjeT, OkamotoOK, MuotriAR and ZatzM. (2008). Multipotent stem cells from umbilical cord: cord is richer than blood!. Stem Cells, 26:146–150.
33.
VieiraNM, BrandaliseV, ZucconiE, JazedjeT, SeccoM, NunesVA, StraussBE, VainzofM and ZatzM. (2008). Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro. Biol Cell, 100:231–241.
34.
PozzobonM, PiccoliM, DitadiA, BolliniS, DestroR, Andre-SchmutzI, MasieroL, LenziniE, ZanescoL, et al. (2009). Mesenchymal stromal cells can be derived from bone marrow CD133+ cells: implications for therapy. Stem Cells Dev, 18:497–510.
35.
LazaridesE and BurridgeK. (1975). Alpha-actinin: immunofluorescent localization of a muscle structural protein in nonmuscle cells. Cell, 6:289–298.
36.
BiressiS, MolinaroM and CossuG. (2007). Cellular heterogeneity during vertebrate skeletal muscle development. Dev Biol, 308:281–293.
37.
ChoiJ, CostaML, MermelsteinCS, ChagasC, HoltzerS and HoltzerH. (1990). MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes. Proc Natl Acad Sci U S A, 87:7988–7992.
38.
ManciniA, SirabellaD, ZhangW, YamazakiH, ShiraoT and KraussRS. (2011). Regulation of myotube formation by the actin-binding factor drebrin. Skelet Muscle, 1:36
39.
LeeKS, KimHJ, LiQL, ChiXZ, UetaC, KomoriT, WozneyJM, KimEG, ChoiJY, RyooHM and BaeSC. (2000). Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol, 20:8783–8792.
40.
TontonozP, HuE and SpiegelmanBM. (1994). Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell, 79:1147–1156.
41.
DucyP, SchinkeT and KarsentyG. (2000). The osteoblast: a sophisticated fibroblast under central surveillance. Science, 289:1501–1504.
42.
LiY, FuFH and HuardJ. (2005). Cutting-edge muscle recovery: using antifibrosis agents to improve healing. Phys Sportsmed, 33:44–50.
43.
LunaL. (1968). Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology. McGraw-Hill Press, New York, NY.
44.
NonakaI, TakagiA, IshiuraS, NakaseH and SugitaH. (1983). Pathophysiology of muscle fiber necrosis induced by bupivacaine hydrochloride (Marcaine). Acta Neuropathol, 60:167–174.
45.
BrooksCL and GuW. (2009). How does SIRT1 affect metabolism, senescence and cancer?. Nat Rev Cancer, 9:123–128.
46.
FeigeJN, LagougeM, CantoC, StrehleA, HoutenSM, MilneJC, LambertPD, MatakiC, ElliottPJ and AuwerxJ. (2008). Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab, 8:347–358.
47.
PardoPS and BoriekAM. (2011). The physiological roles of Sirt1 in skeletal muscle. Aging, 3:430–437.
48.
Gauthier-RouviereC, VandrommeM, TuilD, LautredouN, MorrisM, SoulezM, KahnA, FernandezA and LambN. (1996). Expression and activity of serum response factor is required for expression of the muscle-determining factor MyoD in both dividing and differentiating mouse C2C12 myoblasts. Mol Biol Cell, 7:719–729.
49.
L'HonoreA, LambNJ, VandrommeM, TurowskiP, CarnacG and FernandezA. (2003). MyoD distal regulatory region contains an SRF binding CArG element required for MyoD expression in skeletal myoblasts and during muscle regeneration. Mol Biol Cell, 14:2151–2162.
SakumaK, AkihoM, NakashimaH, AkimaH and YasuharaM. (2008). Age-related reductions in expression of serum response factor and myocardin-related transcription factor A in mouse skeletal muscles. Biochim Biophys Acta, 1782:453–461.
52.
LaBargeMA and BlauHM. (2002). Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell, 111:589–601.
53.
DezawaM, IshikawaH, ItokazuY, YoshiharaT, HoshinoM, TakedaS, IdeC and NabeshimaY. (2005). Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science, 309:314–317.
54.
Le BlancK and MougiakakosD. (2012). Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol, 12:383–396.
55.
CosgroveBD, SaccoA, GilbertPM and BlauHM. (2009). A home away from home: challenges and opportunities in engineering in vitro muscle satellite cell niches. Differentiation, 78:185–194.
56.
BrackAS and RandoTA. (2012). Tissue-specific stem cells: lessons from the skeletal muscle satellite cell. Cell Stem Cell, 10:504–514.
57.
GuarenteL. (2011). H Franklin. Epstein Lecture: Sirtuins, aging, and medicine. N Engl J Med, 364:2235–2244.
58.
BackesjoCM, LiY, LindgrenU and HaldosenLA. (2006). Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells. J Bone Miner Res, 21:993–1002.
59.
TsengPC, HouSM, ChenRJ, PengHW, HsiehCF, KuoML and YenML. (2011). Resveratrol promotes osteogenesis of human mesenchymal stem cells by upregulating RUNX2 gene expression via the SIRT1/FOXO3A axis. J Bone Miner Res, 26:2552–2563.
60.
ConboyIM, ConboyMJ, WagersAJ, GirmaER, WeissmanIL and RandoTA. (2005). Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature, 433:760–764.
61.
ConboyIM and RandoTA. (2005). Aging, stem cells and tissue regeneration: lessons from muscle. Cell Cycle, 4:407–410.
62.
BrackAS, ConboyMJ, RoyS, LeeM, KuoCJ, KellerC and RandoTA. (2007). Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science, 317:807–810.
63.
Martin-RendonE, SweeneyD, LuF, GirdlestoneJ, NavarreteC and WattSM. (2008). 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Vox Sang, 95:137–148.
64.
PaquinJ, DanalacheBA, JankowskiM, McCannSM and GutkowskaJ. (2002). Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes. Proc Natl Acad Sci U S A, 99:9550–9555.
65.
HatamiL, ValojerdiMR and MowlaSJ. (2007). Effects of oxytocin on cardiomyocyte differentiation from mouse embryonic stem cells. Int J Cardiol, 117:80–89.
66.
BossolascoP, CortiS, StrazzerS, BorsottiC, Del BoR, FortunatoF, SalaniS, QuiriciN, BertoliniF, et al. (2004). Skeletal muscle differentiation potential of human adult bone marrow cells. Exp Cell Res, 295:66–78.
67.
LiuY, YanX, SunZ, ChenB, HanQ, LiJ and ZhaoRC. (2007). Flk-1+ adipose-derived mesenchymal stem cells differentiate into skeletal muscle satellite cells and ameliorate muscular dystrophy in mdx mice. Stem Cells Dev, 16:695–706.
68.
HuardJ, RoyR, GueretteB, VerreaultS, TremblayG and TremblayJ. (1994). Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection. Muscle Nerve, 17:224–234.
69.
SwijnenburgRJ, SchrepferS, GovaertJA, CaoF, RansohoffK, SheikhAY, HaddadM, ConnollyAJ, DavisMM, RobbinsRC and WuJC. (2008). Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc Natl Acad Sci U S A, 105:12991–12996.
70.
QuintanaE, ShackletonM, SabelMS, FullenDR, JohnsonTM and MorrisonSJ. (2008). Efficient tumour formation by single human melanoma cells. Nature, 456:593–598.
71.
RosenzweigA. (2006). Cardiac cell therapy—mixed results from mixed cells. N Engl J Med, 355:1274–1277.
72.
SegersVF and LeeRT. (2008). Stem-cell therapy for cardiac disease. Nature, 451:937–942.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
